Low-dose digoxin is being evaluated for its efficacy and safety in improving outcomes for patients with heart failure and reduced or mildly reduced ejection fraction.
Does low-dose digoxin improve outcomes in patients with HFrEF and HFmrEF?
Patients with heart failure with reduced or mildly reduced ejection fraction (HFrEF and HFmrEF)
Low-dose digoxin
The DECISION trial will provide evidence on the efficacy and safety of low-dose digoxin in contemporary patients with HFrEF and HFmrEF.
DECISION enrolled a contemporary and well-treated population of patients with HFrEF and HFmrEF and will provide important evidence regarding the efficacy and safety of low-dose digoxin on outcome in patients with reduced or mildly reduced LVEF.
Building similarity graph...
Analyzing shared references across papers
Loading...
Peter van der Meer
Geert H.D. Voordes
Marlene A. T. Vijver
European Journal of Heart Failure
University of Amsterdam
University of Groningen
Leiden University Medical Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Meer et al. (Thu,) reported a other. Low-dose digoxin is being evaluated for its efficacy and safety in improving outcomes for patients with heart failure and reduced or mildly reduced ejection fraction.
www.synapsesocial.com/papers/69b64d48b42794e3e660e1a0 — DOI: https://doi.org/10.1093/ejhf/xuag073
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: